Tag: Nick Kadysh
-
First authorization for MDMA approved for Canadian patient
Nick Kadysh, CEO of PharmAla discusses the first authorized MDMA treatment of a patient outside of a clinical trial in Canadian history.
Nick Kadysh, CEO of PharmAla discusses the first authorized MDMA treatment of a patient outside of a clinical trial in Canadian history.